Aurobindo Pharma Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Aurobindo Pharma Limited Company Profile :

Aurobindo Pharma Limited is an Indian pharmaceutical company engaged in producing oral and injectable generic formulations and active pharmaceutical.

The company also manufactures and commercializes active pharmaceutical ingredients (APIs) and generic finished dosages for various markets. The Company’s product portfolio is spread over therapeutic/product areas like antibiotics, anti-retrovirals, chorionic villus sampling (CVS), central nervous system (CNS), gastroenterologicals and anti-allergics.


Aurobindo Pharma ResultsBSE Code : 524804
NSE Symbol : AUROPHARMA
ISIN No. : INE406A01037
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Aurobindo Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Aurobindo Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Aurobindo Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Aurobindo Pharma.

Aurobindo Pharma Q1 Results 2016-17 :

Aurobindo Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aurobindo Pharma will announce its Q2 FY 2016-17 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aurobindo Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aurobindo Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aurobindo Pharma will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Aurobindo Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 9166.18 13896.08
Other Income 39.99 68.23
Total Income 9205.47 13964.31
Expenditure -6737.15 -11083.12
Interest -65.27 -92.73
Depreciation -263.00 -392.62
PBT 2140.05 2722.46
Tax -520.38 -744.37
Net Profit  1619.67 1978.09
Equity 58.52 58.52
EPS 27.73 33.93

Note : If you like this information about Aurobindo Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.